| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |